These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 28086874)

  • 1. New developments in anti-malarial target candidate and product profiles.
    Burrows JN; Duparc S; Gutteridge WE; Hooft van Huijsduijnen R; Kaszubska W; Macintyre F; Mazzuri S; Möhrle JJ; Wells TNC
    Malar J; 2017 Jan; 16(1):26. PubMed ID: 28086874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Wells TN
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global pipeline of new medicines for the control and elimination of malaria.
    Anthony MP; Burrows JN; Duparc S; Moehrle JJ; Wells TN
    Malar J; 2012 Sep; 11():316. PubMed ID: 22958514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing the next generation of medicines for malaria control and eradication.
    Burrows JN; van Huijsduijnen RH; Möhrle JJ; Oeuvray C; Wells TN
    Malar J; 2013 Jun; 12():187. PubMed ID: 23742293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria.
    Macintyre F; Ramachandruni H; Burrows JN; Holm R; Thomas A; Möhrle JJ; Duparc S; Hooft van Huijsduijnen R; Greenwood B; Gutteridge WE; Wells TNC; Kaszubska W
    Malar J; 2018 Nov; 17(1):402. PubMed ID: 30384848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The state of the art in anti-malarial drug discovery and development.
    Burrows JN; Chibale K; Wells TN
    Curr Top Med Chem; 2011; 11(10):1226-54. PubMed ID: 21401508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria in South America: a drug discovery perspective.
    Cruz LR; Spangenberg T; Lacerda MV; Wells TN
    Malar J; 2013 May; 12():168. PubMed ID: 23706107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the biology component of the drug discovery strategy for malaria eradication.
    Leroy D; Campo B; Ding XC; Burrows JN; Cherbuin S
    Trends Parasitol; 2014 Oct; 30(10):478-90. PubMed ID: 25131411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering and developing new medicines for malaria control and elimination.
    Wells TN
    Infect Disord Drug Targets; 2013 Aug; 13(4):292-302. PubMed ID: 24304355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The past, present and future of anti-malarial medicines.
    Tse EG; Korsik M; Todd MH
    Malar J; 2019 Mar; 18(1):93. PubMed ID: 30902052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria medicines: a glass half full?
    Wells TN; Hooft van Huijsduijnen R; Van Voorhis WC
    Nat Rev Drug Discov; 2015 Jun; 14(6):424-42. PubMed ID: 26000721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial drug discovery - approaches and progress towards new medicines.
    Flannery EL; Chatterjee AK; Winzeler EA
    Nat Rev Microbiol; 2013 Dec; 11(12):849-62. PubMed ID: 24217412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of gametocyte parameters in anti-malarial drug efficacy studies: filling a neglected gap needed for malaria elimination.
    Abdul-Ghani R; Basco LK; Beier JC; Mahdy MA
    Malar J; 2015 Oct; 14():413. PubMed ID: 26481312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supporting malaria elimination with 21st century antimalarial agent drug discovery.
    Diagana TT
    Drug Discov Today; 2015 Oct; 20(10):1265-70. PubMed ID: 26103616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering New Transmission-Blocking Antimalarial Compounds: Challenges and Opportunities.
    Birkholtz LM; Coetzer TL; Mancama D; Leroy D; Alano P
    Trends Parasitol; 2016 Sep; 32(9):669-681. PubMed ID: 27209388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimalarial pipeline.
    Hooft van Huijsduijnen R; Wells TN
    Curr Opin Pharmacol; 2018 Oct; 42():1-6. PubMed ID: 29860174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges.
    Roy KK
    Int J Antimicrob Agents; 2017 Sep; 50(3):287-302. PubMed ID: 28668681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges facing drug development for malaria.
    Craft JC
    Curr Opin Microbiol; 2008 Oct; 11(5):428-33. PubMed ID: 18824124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in the development of anti-malarial quinolones.
    Beteck RM; Smit FJ; Haynes RK; N'Da DD
    Malar J; 2014 Aug; 13():339. PubMed ID: 25176157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimens.
    Aljayyoussi G; Kay K; Ward SA; Biagini GA
    Malar J; 2016 Jul; 15(1):344. PubMed ID: 27388207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.